Celularity Inc — Director's Dealing 2022

Aug 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2022-08-16

Reporting Person: Smith Robin L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-16	Stock Option (Right to Buy)	$2.99	A	250000	Acquired	2032-08-16	Class A Common Stock (250000)	Direct
2022-08-16	Stock Option (Right to Buy)	$2.99	A	800000	Acquired	2032-08-16	Class A Common Stock (800000)	Direct

Footnotes

F1: This option vested and became exercisable immediately on the grant date.

F2: This option is subject to vesting in four equal tranches, based on achievement of certain pre-defined performance targets, and subject to the Reporting Person's continuous service with the Issuer through each such date.